MHC class II peptide-loading complex (MHC II PLC)

The MHC class II peptide-loading complex is a specialized multi-protein assembly located within the endosomal and lysosomal compartments, specifically the MHC class II compartment (MIIC), of professional antigen-presenting cells (NIH, 2016). Its primary function is to facilitate the exchange of the class II-associated invariant chain peptide (CLIP) for high-affinity antigenic peptides derived from exogenous or endogenous proteins (Wikipedia). The core of this complex involves the non-classical MHC molecule HLA-DM, which acts as a molecular chaperone and catalyst to stabilize empty MHC class II molecules and promote the binding of stable peptides (Frontiers in Immunology, 2017). HLA-DO serves as a critical regulator of HLA-DM, modulating its activity in a pH-dependent manner to fine-tune the presented peptide repertoire (NIH, 2015). This process, often referred to as 'peptide editing,' ensures that only the most stable peptide-MHC complexes are transported to the cell surface for presentation to CD4+ T cells (NIH, 2023). Dysregulation of this complex is implicated in various autoimmune disorders, such as Type 1 Diabetes and Rheumatoid Arthritis, where self-peptides are inappropriately presented (NIH, 2015). In cancer, tumors may downregulate complex components to evade immune detection by CD4+ T cells (NIH, 2016). Therapeutic strategies targeting this complex include HLA-DM inhibitors, cathepsin S inhibitors, and modulators of the invariant chain (CD74) to adjust the immune response in inflammatory and oncological contexts (SCBT, 2024).

Other names

MHC II loading machineryHLA-DM/MHC II complexMIIC loading complexMHC class II antigen presentation complex

Inhibition of HLA-DM catalytic activity, blockade of invariant chain (CD74) processing, and transcriptional downregulation of MHC II components.